Study design and results from the DCCT Study design and results from the DCCT Description What clinical trial endpoints have been shown to improve when ACE inhibitors and/or ARBS are  used in preventing the progression of kidney disease in patients with diabetes?  Which patients with diabetes benefit the most?  At what point is it recommended … Continue reading Study design and results from the DCCT